Benjamin Bovell-Ammon to Adult
This is a "connection" page, showing publications Benjamin Bovell-Ammon has written about Adult.
Connection Strength
0.312
-
Bovell-Ammon BJ, Onofrey S, Kimmel SD, Wurcel AG, Klevens RM. Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study. BMC Public Health. 2026 Jan 30; 26(1).
Score: 0.070
-
Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes. JAMA Netw Open. 2024 03 04; 7(3):e242732.
Score: 0.061
-
Bovell-Ammon BJ, Fox AD, LaRochelle MR. Prior Incarceration Is Associated with Poor Mental Health at Midlife: Findings from a National Longitudinal Cohort Study. J Gen Intern Med. 2023 05; 38(7):1664-1671.
Score: 0.056
-
Bovell-Ammon BJ, Kimmel SD, Cheng DM, Truong V, Michals A, Vetrova M, Hook K, Idrisov B, Blokhina E, Krupitsky E, Samet JH, Lunze K. Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia. Int J Drug Policy. 2023 Jan; 111:103907.
Score: 0.056
-
Patel KS, Bovell-Ammon B, Van Siclen R, Miller W, Zellmer L, Fu SS, Chamberlain AM, Drawz PE, Rossom R, Wilhelm A, Winkelman TNA. Comparison of statewide substance use disorder prevalence estimates from survey data vs electronic health record data. Drug Alcohol Depend. 2026 Oct 01; 287:113313.
Score: 0.018
-
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 07 01; 9(7):e2623280.
Score: 0.018
-
Friedmann PD, Wilson D, Stopka TJ, Bernson D, Pivovarova E, Ferguson W, Hoskinson RA, Rottapel RE, Bovell-Ammon B, Gaba A, Morgan JR, Senst T, Hayes E, Evans EA. Medications for Opioid Use Disorder in County Jails - Outcomes after Release. N Engl J Med. 2025 Sep 11; 393(10):994-1003.
Score: 0.017
-
Lodi S, Yan S, Bovell-Ammon B, Christine PJ, Hsu HE, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Addiction. 2025 Aug; 120(8):1634-1645.
Score: 0.016